NanoViricides (NYSE-A:NNVC) will present today, Nov. 14, at 11:25–11:45 a.m. ET at the Pharma Partnering Summit 2025 in Boston.
President and Executive Chairman Anil R. Diwan, PhD, will provide an update on the company, its antiviral drug pipeline, and platform technologies available for licensing.